Disparities Seen for Racial, Ethnic Minorities in Outpatient Practices
Visit rates lower for Black individuals versus Whites for 23 of 29 specialties, with marked disparities for dermatology, otolaryngology, general surgery (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 24, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Internal Medicine, Allergy, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pediatrics, Psychiatry, Pulmonology, Radiology, Rheumatology, Source Type: news

No Link Between Childhood Vaccinations and Allergies or Asthma No Link Between Childhood Vaccinations and Allergies or Asthma
Analyses of published data showed no connection between childhood allergies and vaccinations.Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - July 24, 2021 Category: Respiratory Medicine Tags: Allergy & Clinical Immunology News Source Type: news

No Link Between Childhood Vaccinations and Allergies or Asthma No Link Between Childhood Vaccinations and Allergies or Asthma
Analyses of published data showed no connection between childhood allergies and vaccinations.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 23, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Childhood Vaccinations and Allergies and Asthma
No Link Between Childhood Vaccinations and Allergies or Asthma (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 23, 2021 Category: General Medicine Source Type: news

UMass Amherst grad student awarded fellowship for food allergy research
(University of Massachusetts Amherst) University of Massachusetts Amherst food science Ph.D. candidate Cassandra Suther has received a prestigious predoctoral fellowship of $180,000 from the U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA-NIFA) to study the effect of norovirus on the development and severity of food allergies. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

Advantages of intranasal vaccination against SARS-CoV-2
(University of Alabama at Birmingham) There are many reasons that an intranasal vaccine against the SARS-CoV-2 virus would be helpful in the fight against COVID-19 infections, University of Alabama at Birmingham immunologists Fran Lund, Ph.D., and Troy Randall, Ph.D., write in a viewpoint article in the journal Science. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2021 Category: Infectious Diseases Source Type: news

Adversity in early life and pregnancy are immunologically distinct from total life adversity: macrophage-associated phenotypes in women exposed to interpersonal violence - Aschbacher K, Hagan M, Steine IM, Rivera L, Cole S, Baccarella A, Epel ES, Lieberman A, Bush NR.
Early childhood and pregnancy are two sensitive periods of heightened immune plasticity, when exposure to adversity may disproportionately increase health risks. However, we need deeper phenotyping to disentangle the impact of adversity during sensitive pe... (Source: SafetyLit)
Source: SafetyLit - July 22, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Covid jab uptake slows among young people in England, PHE says
Scientists say efforts to increase vaccinations by tactics seen as coercive are less useful than good communication via role modelsCoronavirus – latest updatesSee all our coronavirus coverageClearer information and messages from role models are needed to boost Covid vaccination uptake among young people, experts have said, as figures showed that fewer than 60% of 18- to 25-year-olds had received their first jab in England.Adults over the age of 18 have been eligible for vaccination against Covid-19 in England since 18 June. But according to the latestdata from Public Health England (PHE), uptake of the vaccine in you...
Source: Guardian Unlimited Science - July 22, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Vaccines and immunisation Young people Coronavirus Psychology Society Immunology Health Medical research UK news Science Source Type: news

Zimbabwe: Seeking Help Late Costly, Immunologist Warns
[The Herald] The high numbers of people dying from Covid-19 being recorded could be a result of people trying unverified homemade remedies first, then presenting to a health facility when it is already too late for them to be save, a local immunologist has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 22, 2021 Category: African Health Source Type: news

NIH awards more than $20 million to international HIV database centers
(NIH/National Institute of Allergy and Infectious Diseases) NIH has renewed grants to seven regional centers that compose the International epidemiology Databases to Evaluate AIDS (IeDEA), awarding $20.8 million in first-year funding. The 15-year-old IeDEA program efficiently advances knowledge about HIV by pooling and analyzing de-identified health data from more than two million people with HIV on five continents to answer research questions that individual studies cannot address. The grants are expected to last five years and to total an estimated $100 million. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Allergy Information on Food Labels Difficult to Interpret
WEDNESDAY, July 21, 2021 -- Both allergic and nonallergic consumers find allergen information difficult to interpret and often misunderstand precautionary allergen labels (PALs), according to a study published online July 21 in Clinical&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2021 Category: Pharmaceuticals Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Media News - July 21, 2021 Category: Pharmaceuticals Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Investor Update - July 21, 2021 Category: Pharmaceuticals Source Type: news

C is for Vitamin C -- a key ingredient for immune cell function
(La Jolla Institute for Immunology) Regulatory T cells (Tregs) help control inflammation and autoimmunity in the body. Unfortunately, it has proven difficult to find the right molecular ingredients to induce stable iTregs. Now a new study reports that Vitamin C and TET proteins can work together to give Tregs their life-saving power. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Most people find allergy information on food labels unclear
(Wiley) Researchers evaluate consumers' understanding of allergy information on food labels in a study published in Clinical& Experimental Allergy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

What Foods Are Bad for Allergies?
Title: What Foods Are Bad for Allergies?Category: Health and LivingCreated: 7/20/2021 12:00:00 AMLast Editorial Review: 7/20/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - July 20, 2021 Category: Allergy & Immunology Source Type: news

Children's National Hospital and NIAID launch study on long-term impacts of COVID-19 and MIS-C
(Children's National Hospital) Up to 2,000 children and young adults will be enrolled in a study from Children's National Hospital in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) that will examine the long-term effects of COVID-19 and multisystem inflammatory syndrome in children (MIS-C) after these patients have recovered from a COVID-19 infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Food allergies took our daughters from us. We must act now before others suffer the same fate
Emma and Tanya share a tragic bond: both lost their beloved daughters to a food allergy - their children dying frightening, awful deaths as they struggled to breathe. (Source: the Mail online | Health)
Source: the Mail online | Health - July 19, 2021 Category: Consumer Health News Source Type: news

Pfizer Agrees to Pay $345 Mln to Resolve EpiPen Pricing Lawsuit Pfizer Agrees to Pay $345 Mln to Resolve EpiPen Pricing Lawsuit
Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who say they overpaid for EpiPens due to anticompetitive practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

What You Don ’t Know About Food Allergies
Pollen-food reactions, adult onset symptoms and cross reactivity are just some of the surprising ways our bodies respond to food. (Source: NYT Health)
Source: NYT Health - July 19, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Allergies Anaphylactic Shock Food Peanuts Seafood Pollen Sesame Seeds Children and Childhood Source Type: news

Pfizer vaccine: Four 'troubling' side effects that mainly follow second dose of Covid jab
The development and distribution of multiple vaccines against COVID-19 has been an unprecedented achievement. However, the side effects of the vaccines have been a source of concern and controversy at times. There are four "troubling symptoms" commonly reported after the second dose of the Pfizer Covid vaccine, according to an article written in the journal Science Immunology. However, the cause of these symptoms should mostly provide comfort not concern, the journal article states. (Source: Daily Express - Health)
Source: Daily Express - Health - July 19, 2021 Category: Consumer Health News Source Type: news

Make Summer Camp Safe for Your Child With Asthma, Allergies
Title: Make Summer Camp Safe for Your Child With Asthma, AllergiesCategory: Health NewsCreated: 7/18/2021 12:00:00 AMLast Editorial Review: 7/19/2021 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - July 19, 2021 Category: Respiratory Medicine Source Type: news

In vitro Zoo helps in understanding SARS-CoV-2
(University of Bern) A team of researchers from the University of Bern and the Institute of Virology and Immunology (IVI) have used a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals to determine which animals are susceptibly to SARS-CoV-2 infection. The team found that SARS-CoV-2 efficiently infected respiratory cells from monkey and cats, and proposes that SARS-CoV-2 surveillance in these animals and its close relatives is necessary. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2021 Category: Infectious Diseases Source Type: news

Preparing T cells for the long haul
(La Jolla Institute for Immunology) In a new Nature Immunology study, researchers at La Jolla Institute for Immunology (LJI) report that T cells can be engineered to clear tumors without succumbing to T cell exhaustion. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 19, 2021 Category: Cancer & Oncology Source Type: news

Make Summer Camp Safe for Your Child With Asthma, Allergies
SUNDAY, July 18, 2021 -- With many summer camps open again this year, parents of kids with asthma and allergies need to make sure the one they choose is safe for their youngsters. While federal health officials have issued guidelines to protect... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 18, 2021 Category: General Medicine Source Type: news

Ruxolitinib Best Option When Glucocorticoids Fail Against Chronic GVHD Ruxolitinib Best Option When Glucocorticoids Fail Against Chronic GVHD
When chronic graft-versus-host disease follows an allogeneic stem-cell transplant, and it's either resistant to standard glucocorticoid therapy or dependent on glucocorticoids, according to the REACH3 trial.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 16, 2021 Category: Transplant Surgery Tags: Allergy & Clinical Immunology News Source Type: news

$340 Million Settlement Proposed in EpiPen Lawsuits
Title: $340 Million Settlement Proposed in EpiPen LawsuitsCategory: Health NewsCreated: 7/16/2021 12:00:00 AMLast Editorial Review: 7/16/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - July 16, 2021 Category: Allergy & Immunology Source Type: news

What You Need to Know About COVID-19 Booster Shots
Since the U.S. began a massive country-wide vaccination effort against COVID-19 last winter, a majority of adult Americans have been immunized. But now it seems that all of them may need an additional dose next year. Public health experts including Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, stress that studies continue to show that the three vaccines currently authorized in the U.S. protect against COVID-19 disease, including against variants of the virus that are more transmissible. But as effective as the vaccines are, they can’t provide 100% immunity against disease. ...
Source: TIME: Health - July 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Anaphylaxis Caused by Artisanal Honey in a Child Anaphylaxis Caused by Artisanal Honey in a Child
This case of anaphylaxis in a 5-year-old boy highlights the potentially serious consequences of honey allergy, especially in patients sensitized to weed pollens.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 15, 2021 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Benralizumab Promising for Rhinosinusitis With Nasal Polyps Benralizumab Promising for Rhinosinusitis With Nasal Polyps
Benralizumab reduced both nasal polyp and nasal blockage scores significantly. This hard-to-treat disease with severe patient burden has few existing pharmacologic treatments.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 15, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Heart problems resolve in majority of kids with COVID inflammatory syndrome
(Columbia University Irving Medical Center) Most of the heart and immunologic problems seen in children with multisystem inflammatory syndrome (MIS-C)--a condition linked to COVID--were gone within a few months, Columbia researchers have found. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 15, 2021 Category: Infectious Diseases Source Type: news

New COVID-19 vaccine candidate provides effective option for low- to mid-income countries
(Emory Health Sciences) Combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be easy to produce at large scale and cost-effective, important aspects for vaccinating people worldwide, especially in low- to middle-income countries. Results from the study, which applied lessons learned from the hepatitis b vaccine platform technology, are published online today in Science Immunology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Innovation Announces Extension Of Innovation Partnering Office at Monash University In Collaboration With Victorian State Government To Accelerate The Life-Sciences Hub
MELBOURNE, Australia, July 15, 2021 -- Johnson & Johnson Innovation announced today the extension of the Johnson & Johnson Innovation Partnering Office at Monash University's Clayton Campus in Melbourne (JJIPO@Monash) in collaboration with the Victorian State Government.This joint initiative between Johnson & Johnson Innovation, the Victorian Government and Monash University will be extended for approximately two years through June 30, 2023. The agreement will allow JJIPO@Monash to continue connecting with the Victorian innovation ecosystem, nurturing and accelerating innovative research, new product developmen...
Source: Johnson and Johnson - July 15, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Dual Mechanisms of Protection Against Delta and Other SARS-CoV-2 Variants of Concern in Data Published in New England Journal of Medicine
NEW BRUNSWICK, N.J., July 14, 2021 – Interim results from a Phase 1/2a sub-study published in the New England Journal of Medicine (NEJM) demonstrated that both humoral (antibody) and cellular (T-cell) immune responses generated by the Johnson & Johnson single-shot COVID-19 vaccine were strong and stable through eight months after immunization, the length of time evaluated to date. Data showed that T-cell responses – including the important CD8+ T-cells that seek out and destroy infected cells – persisted over the eight-month timeframe examined. The Company announced topline preprint study results from...
Source: Johnson and Johnson - July 14, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Tezepelumab Reduces Asthma Exacerbation Rates by 56% Tezepelumab Reduces Asthma Exacerbation Rates by 56%
The biologic reduced the annualized exacerbation rate in a broad group of patients with severe asthma by 56% in the phase 3 NAVIGATOR trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 14, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

What Causes Nose Allergies?
Title: What Causes Nose Allergies?Category: Diseases and ConditionsCreated: 7/14/2021 12:00:00 AMLast Editorial Review: 7/14/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - July 14, 2021 Category: Allergy & Immunology Source Type: news

What Foods Cause Oral Allergy Syndrome?
Title: What Foods Cause Oral Allergy Syndrome?Category: Diseases and ConditionsCreated: 7/14/2021 12:00:00 AMLast Editorial Review: 7/14/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - July 14, 2021 Category: Allergy & Immunology Source Type: news

Big Pharma cashing in on the plandemic: $19 BILLION for Moderna in just one year
(Natural News) Thanks to Donald Trump’s “Operation Warp Speed” scheme, drug giant Moderna is slated to rake in record profits this year with a revenue forecast of a whopping $19.2 billion. Tony Fauci also contributed by laundering gobs of taxpayer cash to Moderna through his National Institute of Allergy and Infectious Diseases (NIAID), which also... (Source: NaturalNews.com)
Source: NaturalNews.com - July 14, 2021 Category: Consumer Health News Source Type: news

What Can You Do for Severe Allergies?
Title: What Can You Do for Severe Allergies?Category: Health and LivingCreated: 7/13/2021 12:00:00 AMLast Editorial Review: 7/13/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - July 13, 2021 Category: Allergy & Immunology Source Type: news

UV Light Linked to Prevention of Allergic Disease in Infants UV Light Linked to Prevention of Allergic Disease in Infants
Researchers also find UV light exposure appears more beneficial than vitamin D supplements as an allergy prevention strategy in the critical early years for immune system development.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

More complex than we thought: The body's reaction to contact allergens
(University of Copenhagen - The Faculty of Health and Medical Sciences) About one in five Danes react to contact allergens, but some patients develop rashes and itching much faster than others. Previously the scientists were unable to explain why, but now researchers from the University of Copenhagen have outlined an entire new subgroup of allergic reactions which explains these early skin reactions. The new knowledge is vital to understanding the disease mechanisms in contact allergy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2021 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Statement on COVID-19 Vaccine (7/12)
NEW BRUNSWICK, N.J., July 12, 2021 – The safety and well-being of the people who use our products is our number one priority. Rare cases of the neurological disorder, Guillain-Barré syndrome have been reported following vaccination with the Janssen COVID-19 vaccine. Most occurred within 42 days after vaccination. While the chance of having this occur is very low, Johnson & Johnson has updated its COVID-19 Vaccine Factsheet to include important information about these rare cases and on the signs and symptoms of Guillain-Barré syndrome. Updates with this new information will be implemented in other regions...
Source: Johnson and Johnson - July 12, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

First actionable clock that predicts immunological health and chronic diseases of aging
(Buck Institute for Research on Aging) Researchers have created an inflammatory clock of aging (iAge) which measures inflammatory load and predicts multi-morbidity, frailty, immune health, cardiovascular aging and is also associated with exceptional longevity in centenarians. Utilizing deep learning, a form of AI, in studies of the blood immunome of 1001 people, researchers also identified a modifiable chemokine associated with cardiac aging which can be used for early detection of age-related pathology and provides a target for interventions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 12, 2021 Category: International Medicine & Public Health Source Type: news

Naturally abundant venom peptide from ants can activate a pseudo allergic pathway unravelling a novel immunomodulatory pathway of MRGPRX2
(The University of Hong Kong) Ants are omnipresent, and we often get blisters after an ant bite. But do you know the molecular mechanism behind it? A joint research team have identified and demonstrated a novel small peptide isolated from the ant venom can initiate an immune pathway via a pseudo-allergic receptor MRGPRX2. The study has recently been published in a top journal in Allergy - The Journal of Allergy and Clinical Immunology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 12, 2021 Category: Biology Source Type: news

Short-Acting Beta Agonist Overuse'a Global Public Health Issue'Short-Acting Beta Agonist Overuse'a Global Public Health Issue '
Overreliance on SABAs and underuse of inhaled corticosteroids are associated with increased risk of exacerbations and asthma-related death.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Vaxxers by Sarah Gilbert and Catherine Green; Until Proven Safe by Geoff Manaugh and Nicola Twilley – reviews
The story of the Oxford AstraZeneca vaccine is part manifesto for good science communications, part biomedical thriller, while a smart history of quarantines makes their utility resoundingly clearOn the first day of Wimbledon, Dame Sarah Gilbert, professor of vaccinology at Oxford ’s Jenner Institute, wastreated to a standing ovation from grateful spectators on a packed Centre Court. Together with her Oxford colleague Catherine Green, Gilbert had delivered the AstraZeneca vaccine against Covid-19in record time, and tennis fans, enjoying a rare maskless day out in SW19, were keen to show their appreciation. But as Gil...
Source: Guardian Unlimited Science - July 11, 2021 Category: Science Authors: Mark Honigsbaum Tags: Science and nature books History books AstraZeneca Immunology Coronavirus Infectious diseases Medical research Culture Source Type: news

Dupilumab Safe, Effective in Kids With Moderate-to-Severe Asthma Dupilumab Safe, Effective in Kids With Moderate-to-Severe Asthma
Adding the dupilumab option for children in this age group is"huge," says one expert.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 10, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Eaaci 2021 eaaci 2021
Read clinically focused news coverage of key developments from EAACI 2021Medscape Allergy & Immunology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 9, 2021 Category: Consumer Health News Tags: None Conference Coverage Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Can I Give My Child for Allergies?
Title: What Can I Give My Child for Allergies?Category: Health and LivingCreated: 7/9/2021 12:00:00 AMLast Editorial Review: 7/9/2021 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - July 9, 2021 Category: Pediatrics Source Type: news